Single-center, consecutive series study of the use of a novel platelet-rich fibrin matrix (PRFM) and beta-tricalcium phosphate in posterolateral lumbar fusion
European Spine Journal Apr 12, 2019
Callanan TC, et al. - Fifty candidates who underwent one-level to three-level posterolateral lumbar fusion procedures were examined to study the radiographic and clinical consequences of combined platelet-rich fibrin matrix (PRFM) and beta-tricalcium phosphate (β-TCP), and bone marrow aspirate (BMA) as a graft alternative in posterolateral lumbar fusion procedures. They found radiographic fusion in 92.4% of operated levels at 1-year follow-up. Significant improvement was reported in VAS scores for both back and leg pain. A decline by 38% was recorded in the number of patients using opioid analgesics at 12-months when compared to baseline figures. They found retiring in 31 cases, although, 68% of employed subjects were able to return to work.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries